- Research works
- 29 ▼ 21% vs 2013–17
- Citations
- 1.1k 38.9 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 18% world 28%
Not ranked overall: Medosome Biotec (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 7.8×. Every wedge is a field page.
Who are the top researchers at Medosome Biotec (United States)?
Ranked on the composite score, John F. Howes lead among researchers whose main affiliation is Medosome Biotec (United States).
- 1 John F. Howes United States · #240,950 worldwide 129 citations · 29 works
Which keywords describe research at Medosome Biotec (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Oxidative Stress, Antioxidant, Neuroprotection, Gene Therapy, Inflammation, Conservation, Phylogeny and Taxonomy.
- Vascular Flora
- Phenolic Compounds
- Drug Resistance
- Phylogeny
- Gene Therapy
- Epidemiology
- Antioxidant
- Oxidative Stress
- Inflammation
- Neuroprotection
- Conservation
- Taxonomy
- Mediterranean
- Radical Scavenging
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 14 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 14 words, with their numbers
- Oxidative Stress3▲ 6.2×12 topics
- Antioxidant2▲ 9.5×3 topics
- Inflammation2▲ 2.7×9 topics
- Epidemiology2▲ 1.31×9 topics
- Neuroprotection1▲ 12×4 topics
- Gene Therapy1▲ 16×2 topics
- Conservation1▲ 7.9×2 topics
- Phylogeny1▲ 21×2 topics
- Taxonomy1▲ 25×2 topics
- Drug Resistance1▲ 11×3 topics
- Mediterranean1▲ 33×1 topic
- Phenolic Compounds1▲ 21×1 topic
- Radical Scavenging1▲ 106×1 topic
- Vascular Flora1▲ 241×1 topic
Which research topics does Medosome Biotec (United States) publish most on?
By volume in 2022–2025: CAR-T cell therapy research, Global Trade and Competitiveness, Virus-based gene therapy research and CRISPR and Genetic Engineering.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 CAR-T cell therapy research Oncology 0 works
- 2 Global Trade and Competitiveness Strategy and Management 0 works
- 3 Virus-based gene therapy research Genetics 0 works
- 4 CRISPR and Genetic Engineering Molecular Biology 0 works
- 5 Economics of Agriculture and Food Markets Economics and Econometrics 0 works
- 6 Natural Products and Biological Research Surgery 0 works
- 7 American Environmental and Regional History Management, Monitoring, Policy and Law 0 works
- 8 Apelin-related biomedical research Pharmacology 0 works
- 9 Forest Management and Policy Global and Planetary Change 0 works
- 10 Genetic Syndromes and Imprinting Genetics 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Medosome Biotec (United States)'s research output changed?
Output in 2018–2022 was 21% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Alachua
- Nanotherapeutics (United States)
- Applied Genetic Technologies (United States)
- Banyan Biomarkers (United States)
- Optima Neuroscience (United States)
- Alchem Laboratories (United States)
- RTI Surgical (United States)
- Tucker-Davis Technologies (United States)
- Applied Food Technologies (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.